Valuation Clinuvel Pharmaceuticals Limited

Stocks

Market Closed - Australian S.E. 09:10:12 13/11/2026 +04			5-day change	1st Jan Change
7.420 ^AUD	-2.88%		-1.33%	-40.45%

11-07	Clinuvel Pharmaceuticals Limited - Shareholder/Analyst Call
10-30	Clinuvel Pharmaceuticals Ltd Files Neuracthel Instant Dossier	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	733.7	883.5	769.8	520.3	518.4	385.3	-	-
Change	-	20.4%	-12.87%	-32.41%	-0.36%	-25.68%	-	-
Enterprise Value (EV) ¹	612.2	726.6	585.9	296.2	309.1	102.2	69.65	32.16
Change	-	18.69%	-19.37%	-49.45%	4.37%	-66.95%	-31.82%	-53.82%
P/E	36.8x	30.3x	22x	14.5x	15.4x	11.1x	10.7x	7.48x
PBR	5.84x	5.37x	3.79x	2.17x	1.91x	1.26x	1.14x	1x
PEG	-	0.6x	1.2x	5.06x	-2.21x	3.34x	2.84x	0.2x
Capitalization / Revenue	11.2x	11.3x	8.73x	5.48x	5.51x	4.08x	3.84x	2.87x
EV / Revenue	9.32x	9.28x	6.64x	3.12x	3.29x	1.08x	0.69x	0.24x
EV / EBITDA	16.4x	19.5x	12x	6.84x	8.09x	2.71x	1.77x	0.55x
EV / EBIT	16.7x	20x	12.3x	7.03x	8.31x	2.79x	1.83x	0.57x
EV / FCF	15.5x	20.2x	18.6x	7.26x	8.76x	2.79x	1.73x	0.58x
FCF Yield	6.44%	4.94%	5.37%	13.8%	11.4%	35.8%	57.7%	174%
Dividend per Share ²	0.04	0.05	0.05	0.05	0.05	0.0547	0.0592	0.0832
Rate of return	0.27%	0.28%	0.33%	0.48%	0.49%	0.72%	0.77%	1.09%
EPS ²	0.403	0.591	0.698	0.718	0.668	0.6902	0.7162	1.021
Distribution rate	9.93%	8.46%	7.16%	6.96%	7.49%	7.92%	8.26%	8.15%
Net sales ¹	65.72	78.32	88.18	95.02	94.02	94.47	100.4	134.4
EBITDA ¹	37.44	37.2	48.95	43.3	38.2	37.75	39.3	57.96
EBIT ¹	36.68	36.41	47.81	42.12	37.21	36.65	38.13	56.47
Net income ¹	20.88	30.6	35.64	36.17	33.92	34.94	36.32	51.72
Net Debt ¹	-121.5	-156.8	-183.9	-224.1	-209.3	-283.1	-315.6	-353.1
Reference price ²	14.850	17.880	15.370	10.380	10.280	7.640	7.640	7.640
Nbr of stocks (in thousands)	49,410	49,410	50,083	50,124	50,428	50,428	-	-
Announcement Date	30/08/22	29/08/23	28/08/24	27/08/25	27/08/26	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CLINUVEL PHARMACEUTICALS LIMITED	11.07x	1.08x	2.71x	0.72%	262M
ELI LILLY AND COMPANY	41.92x	14.14x	29.98x	0.48%	1,271B
JOHNSON & JOHNSON	41.5x	6.96x	19.58x	1.88%	683B
ABBVIE INC.	37.54x	8.61x	17.78x	2.34%	520B
ROCHE HOLDING AG	21.85x	5.3x	13.27x	2.47%	389B
MERCK & CO., INC.	104.3x	5.95x	25.36x	2.31%	362B
NOVARTIS AG	24.13x	5.85x	14.24x	2.72%	304B
ASTRAZENECA PLC	24.18x	4.84x	13.59x	1.81%	286B
AMGEN INC.	24.11x	7.4x	13.59x	2.16%	253B
GILEAD SCIENCES, INC.	-39.46x	7.31x	46.04x	1.97%	208B
Average	29.11x	6.74x	19.61x	1.88%	428B
Weighted average by Cap.	37.31x	8.88x	22.52x	1.69%